The potential impact of vaporized nicotine products on vulnerable subpopulations

Addiction

Volumn 112, Issue 1, 2017, Pages 18-19

  Gartner, Coral ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

E cigarettes; harm reduction; health disparities; modelling; nicotine; tobacco; vulnerable populations

Indexed keywords

NICOTINE; NICOTINE GUM;

ELECTRONIC CIGARETTE; HARM REDUCTION; SMOKING CESSATION; TOBACCO;

ELECTRONIC NICOTINE DELIVERY SYSTEMS; HARM REDUCTION; NICOTINE; SMOKING CESSATION; TOBACCO PRODUCTS; TOBACCO USE CESSATION PRODUCTS;

EID: 84966378459     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13404     Document Type: Note

References (20)

1. Levy D., Cummings M., Villanti A., Niaura R., Abrams D., Fong G., et al. A framework for evaluating the public health impact of E-cigarettes and other vaporized nicotine products. Addiction 2017; 112: 8–17.
2. Australian Institute of Health and Welfare (AIHW) In: AIHW, editor. National Drug Strategy Household Survey Detailed Report: 2013—Supplementary tables. Canberra; 2014.
3. Baker A., Baker A., Ivers R. G., Baker A., Ivers R. G., Bowman J., et al. Where there's smoke, there's fire: high prevalence of smoking among some sub-populations and recommendations for intervention. Drug Alcohol Rev 2006; 25: 85–96.
4. Rasmussen L., Helleberg M., May M. T., Afzal S., Kronborg G., Larsen C. S., et al. Myocardial infarction among Danish HIV-infected individuals. Clin Infect Dis 2015; 60: 1415–23.
5. Morris A., George M. P., Crothers K., Huang L., Lucht L., Kessinger C., et al. HIV and COPD: is it worse and why? Proc Am Thorac Soc 2011; 8: 320–5.
6. Fujita Y., Shibata A., Ogimoto I., Kurozawa Y., Nose T., Yoshimura T., et al. The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer 2006; 94: 737–9.
7. Hézode C., Lonjon I., Roudot-Thoraval F., Mavier J.-P., Pawlotsky J.-M., Zafrani E. S., et al. Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 2003; 52: 126–9.
8. Kanazawa H., Hirata K., Yoshikawa J. Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection. Chest 2003; 123: 596–9.
9. Gartner C., Hall W. Tobacco harm reduction in people with serious mental illnesses. Lancet Psychiatry 2015; 2: 485.
10. Moeller-Saxone K. Cigarette smoking and interest in quitting among consumers at a Psychiatric Disability Rehabilitation and Support Service in Victoria, Australian and New Zealand. J Public Health 2008; 32: 479–81.
11. Moscou-Jackson G., Commodore-Mensah Y., Farley J., DiGiacomo M. Smoking-cessation interventions in people living with HIV infection: a systematic review. J Assoc Nurses AIDS Care 2014; 25: 32–45.
12. Nahvi S., Richter K., Li X., Modali L., Arnsten J. Cigarette smoking and interest in quitting in methadone maintenance patients. Addict Behav 2006; 31: 2127–34.
13. Richter K., Gibson C., Ahluwalia J., Schmelzle K. Tobacco use and quit attempts among methadone maintenance clients. Am J Public Health 2001; 91: 296–9.
14. Stockings E., Bowman J., McElwaine K., Baker A., Terry M., Clancy R., et al. Readiness to quit smoking and quit attempts among Australian mental health inpatients. Nicotine Tob Res 2013; 15: 942–9.
15. Mdodo R., Frazier E. L., Dube S. R., Mattson C. L., Sutton M. Y., Brooks J. T., et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States. Ann Intern Med 2015; 162: 335–44.
16. Lawrence D., Considine J., Mitrou F., Zubrick S. Anxiety disorders and cigarette smoking: results from the Australian survey of mental health and Wellbeing, the Australian and New Zealand. J Psychohist 2010; 44: 520–7.
17. Morgan V., Waterreus A., Jablensky A., Mackinnon A., McGrath J., Carr V., et al. People Living With Psychotic Illness 2010: Report on the Second Australian national survey. Canberra: Australian Government; 2011.
18. Twyman L., Bonevski B., Paul C., Bryant J., Gartner C., Guillaumier A. Electronic cigarettes: awareness, recent use, and attitudes within a sample of socioeconomically disadvantaged Australian smokers. Nicotine Tob Res 2016; 18: 670–7.
19. Cummins S. E., Zhu S.-H., Tedeschi G. J., Gamst A. C., Myers M. G. Use of e-cigarettes by individuals with mental health conditions. Tob Control 2014; 23: 48–53.
20. Sutherland R., Sindicich N., Entwistle G., Whittaker E., Peacock A., Matthews A., et al. Tobacco and e-cigarette use amongst illicit drug users in Australia. Drug Alcohol Depend 2016; 159: 35–41.